EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

HASS Corp (450330) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of HASS Corp KRW 3,394, price KRW 4,900, upside -30.7%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · KR

HC Some data Sep 24, 2026

HASS Corp

450330 · KQ

Weak valuationQuality is weak on top of the rich price.

!Fair value 3,394 KRW · Overvalued (−31%)
!Quality 36/100
!Expensive Growth (revenue 3y +3.6 %/yr)
!Thin margins · 8.5% net margin (TTM)
!Low debt · negative free cash flow
·1.22% dividend yield
!Trails peers (2/9)
!Narrow moat 28/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 13 out of 100
!Weak on dividend: 24 out of 100
Watch HASS Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

16,819 KRW 3,790 KRW Fair Value 3,394 KRW Jul 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

27‑month range 3,790 KRW – 16,819 KRW · fair‑value band 2,545 KRW – 4,242 KRW · the 4,900 KRW price screens above the 3,394 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow HASS in your weekly email

Every Wednesday you see whether HASS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Hass Corp. manufactures and sells dental medical devices.

Show more

Hass Corp. manufactures and sells dental medical devices. Its CAD/CAM systems include Amber Mill, a machinable dental glass-ceramic blocks made of lithium disilicate; Amber Mill Direct, a CAD/CAM-based millable lithium disilicate block; Amber Mill H, a CAD/CAM block using nano-crystalline ceramics particle; Amber Mill Q, an implant abutment solution; and Amber Mill Meso, a lithium disilicate-based block for implant prosthese. The company's heat-pressing systems comprise Amber Press, a lithium disilicate-based press ingots; Amber Press Master, a lithium disilicate-based high fusion press ingots; and Amber LiSi-POZ and Amber LiSi-POM for lithium disilicate-based press on zirconia. In addition, it offers Amber Vest, an ultra-fine phosphate bound investment for pressable dental ceramics; COCO Lux, a mobile dental photography solution; Selection Tip, a shade matching solution; and Amber Glow, a polish for zirconia, lithium disilicate, porcenlain, and composite. The company was founded in 2008 and is headquartered in Gangneung-si, South Korea.

Stock analysis

HASS Corp (450330) currently trades at 4,900 KRW, while our model-based Fair Value estimate is 3,394 KRW, implying the stock looks roughly 44.4% overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of 4,008 KRW per share, and 1 of the 14 models we run sit above the 4,900 KRW price.

Bear case: the Earnings-Based group reads lowest at 1,727 KRW, and 13 of the 14 models stay below the price. Evidence for this calculation is medium.

Scenario range: 2,545 KRW (bear) to 4,242 KRW (bull), the price of 4,900 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

HASS Corp reported revenue of 16.6B KRW in FY2025 versus 12.6B KRW in FY2021, a compound +7.1%/yr. Reported net income was 1.5B KRW in FY2025, compounding −0.2%/yr from FY2021.

Key figures

Market cap 40.1B KRW (≈ $29.5M) · P/S ratio 1.99 · Dividend yield 1.2% · Net margin 9.3% · Return on equity 3.3% · Return on assets (EBIT) 7.1% · Operating margin −24.7% · Revenue (TTM) 16.6B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).

What moves the price

The share trades about 37% below its 52-week high and 29% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −13% fair-value upside, at −31%, 450330 screens richer than that median.

Fair Value models

Bear 2,545 KRW Fair Value 3,394 KRW Bull 4,242 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings 2,263 KRW 2,888 KRW 3,743 KRW 75
Residual Income 4,305 KRW 4,178 KRW 3,532 KRW 73
EPV 1,595 KRW 1,727 KRW 1,841 KRW 71
All 14 models by family
DCF Models
Owner Earnings 2,263 KRW 2,888 KRW 3,743 KRW 75
Earnings-Based
Graham-Dodd 1,358 KRW 3,194 KRW 4,111 KRW 63
PEG = 1.0 549.22 KRW 784.59 KRW 1,020 KRW 55
EPV 1,595 KRW 1,727 KRW 1,841 KRW 71
Multiples
P/E Multiple 3,294 KRW 4,392 KRW 5,490 KRW 63
P/S Multiple 2,545 KRW 3,394 KRW 4,242 KRW 58
P/B Multiple 2,545 KRW 3,394 KRW 4,242 KRW 55
EV/EBIT 2,244 KRW 2,739 KRW 3,233 KRW 66
EV/EBITDA 4,311 KRW 5,495 KRW 6,679 KRW 67
EV/Revenue 1,819 KRW 2,273 KRW 2,727 KRW 54
Asset-Based
NCAV (Graham) 2,991 KRW 4,008 KRW 5,982 KRW 54
Economic Profit
Residual Income 4,305 KRW 4,178 KRW 3,532 KRW 73
ROIC Compounder 1,595 KRW 1,727 KRW 1,841 KRW 69
Growth Earnings
Growth-Adj P/E 2,486 KRW 3,552 KRW 4,617 KRW 65

Open the full fair value analysis →

Notify me when 450330 reaches fair value

Put 450330 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 36/100

Of which business quality 40 · Market factors (momentum, volatility) 32

Profitability 29
Margins and returns on capital today
Quality Growth 44
Are margins and returns improving?
Cashflow 25
Earnings quality: real cash, not paper profit
Fin. Strength 72
Balance sheet, leverage, solvency risk
Investment 12
Disciplined investing over empire-building
Low Volatility 60
Calm price path (market factor)
Momentum 24
Price trend over the last 3–12 months (market factor)
52W Momentum 14
Distance to the 52-week high (market factor)
Net Issuance 52
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 33/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+0.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−1.0%
Dividend (yield on the price)1.2%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 5%

450330 screens 44% overvalued. Compare with Intuitive Surgical, Inc →

Compare HASS Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 204 stocks

Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 36 · Bottom 25%
Fair Value upside −31% · Below median
Profitability
Return on equity (TTM) 3% · Below median
Return on assets 1% · Below median
Net margin (TTM) 8% · Above median
Operating margin (TTM) −25% · Bottom 25%
Growth and dividend
Revenue growth −1% · Below median
Dividend yield (TTM) 1.2% · Below median
Balance sheet
Debt / equity 0.03× · Below median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 14
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)13 · sector 25
HEALTH (low debt)99 · sector 96
DIVIDEND (yield)24 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $399.52 $348.72 −13%
EssilorLuxottica Société anonyme EL €144.70 €159.17 +10%
Medline Inc MDLN $34.30 $30.15 −12%
Becton, Dickinson and Company BDX $182.52 $103.53 −43%
Alcon Inc ALC $65.39 $39.78 −39%
ResMed Inc RMD A$31.70 A$34.87 +10%
West Pharmaceutical Services, Inc WST $375.87 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €215.80 €54.82 −75%
Straumann Holding STMN CHF 96.38 CHF 45.50 −53%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

HASS Corp · Fair Value
3,394 KRW −44%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "HASS Corp Fair Value". https://www.fairvalue-calculator.com/stock/450330

Frequently asked questions

Is HASS Corp (450330) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 3,394 KRW versus a price of 4,900 KRW, about −31% upside (overvalued).
What is the fair value of 450330?
Our model-based fair value for HASS Corp is 3,394 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 4,900 KRW.
What is the quality score of 450330?
HASS Corp has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HASS Corp (450330)?
Our model-based price target is the fair value of 3,394 KRW (as of Sep 24, 2026) from 14 valuation models. Cautious scenario 2,545 KRW, optimistic scenario 4,242 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the HASS Corp stock forecast for 2026?
Our models put fair value at 3,394 KRW, about −31% upside versus a price of 4,900 KRW (overvalued). Cautious scenario 2,545 KRW, optimistic scenario 4,242 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of HASS Corp (450330)?
HASS Corp reported trailing-twelve-month revenue of about 16.6B KRW (latest available figure, as of Sep 24, 2026).
Does HASS Corp pay a dividend?
HASS Corp currently shows a dividend yield of about 1.22% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of HASS Corp (450330)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HASS Corp it is 3,394 KRW per share (as of Sep 24, 2026), against a price of 4,900 KRW. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is HASS Corp stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 450330 trades above its calculated fair value: price 4,900 KRW, fair value 3,394 KRW, a gap of about −31% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 450330?
No. The price is what the market pays today (4,900 KRW); the fair value is what the company's own numbers justify (3,394 KRW). For HASS Corp the two are 1,506 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is HASS Corp worth?
The market values HASS Corp at about 40.1B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 4,900 KRW; our models calculate a fair value of 3,394 KRW per share.
What do the bullish and bearish scenarios say about 450330?
Our models span a range for HASS Corp: cautious scenario 2,545 KRW, base 3,394 KRW, optimistic 4,242 KRW per share (as of Sep 24, 2026, price 4,900 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HASS Corp (450330)?
Balance-sheet figures for HASS Corp (as of Sep 24, 2026): return on equity 3.3%, debt of 0.03 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 450330 from its 52-week high?
HASS Corp trades at 4,900 KRW, about 37% below its 52-week high of 7,800 KRW and 29% above the low of 3,790 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 3,394 KRW is for.
Which stocks are comparable to HASS Corp?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HASS Corp stock attractive at the current price?
The data as of Sep 24, 2026: price 4,900 KRW, calculated fair value 3,394 KRW (−31%), Quality Score 36/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 450330 calculated?
We run HASS Corp through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 3,394 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. HASS Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HASS Corp (450330)?
The closing price on Sep 23, 2026 was 4,900 KRW. Our model-based fair value is 3,394 KRW, about −31% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HASS Corp right now?
The price sits above even our optimistic bull case (4,242 KRW). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of HASS Corp

How large is the market capitalisation of HASS Corp (450330)?
The market capitalisation of HASS Corp is 40.1B KRW (≈ $29.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HASS Corp (450330)?
The price-to-sales ratio of HASS Corp is 1.99 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of HASS Corp (450330)?
The dividend yield of HASS Corp is 1.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of HASS Corp (450330)?
The net margin of HASS Corp is 9.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HASS Corp (450330)?
The return on equity (ROE) of HASS Corp is 3.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HASS Corp (450330)?
On an EBIT basis the return on assets of HASS Corp is 7.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HASS Corp (450330)?
The operating margin of HASS Corp is −24.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HASS Corp (450330)?
Revenue at HASS Corp is growing −0.5% versus a year earlier (3y avg +3.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HASS Corp (450330)?
Earnings per share at HASS Corp are growing −11.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does HASS Corp (450330) generate?
The free cash flow of HASS Corp is −409M KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does HASS Corp (450330) carry?
The net debt of HASS Corp is 4.4B KRW (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch HASS Corp in the live analysis

One click puts HASS Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.